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Abstract
Oxidative metabolism and its possible modulation by nitric oxide (NO) was examined in endothelial-intact and
endothelial-denuded segments of porcine carotid arteries. Endothelial-intact arteries displayed appropriate NO-mediated
vasorelaxation to acetylcholine (ACh). Endothelial-denuded arteries demonstrated absent vasorelaxation to ACh stimulation
and depressed contractile responsiveness to K depolarization, which was normalized by inhibition of NO synthesis by Ng-
nitro-L-arginine methylester (L-NAME). Confirmation that carotid arteries continued to produce NO despite removal of the
endothelium was indicated by detection of NO metabolites in the incubation medium bathing the arteries. O2 consumption
and the oxidation of glucose and fatty acid were depressed in endothelial-denuded arteries. Depression of O2 consumption
and glucose oxidation was completely reversed by treatment with L-NAME. We conclude that endogenous NO produced by
non-endothelial vascular cells depresses contractility, O2 consumption, and oxidation of energy substrates in vascular smooth
muscle. The endothelium may play a role in oxidative metabolism of vascular smooth muscle possibly by modulating the
effects of NO produced by other cells of the vessel wall, or by other factors. ß 2001 Elsevier Science B.V. All rights
reserved.
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1. Introduction
The endothelial layer of the vascular wall is known
to exert important regulatory functions over the
underlying media muscularis [1]. This regulation is
e¡ected predominately by several vasoactive media-
tors released from the endothelium in a paracine
fashion to a¡ect the subjacent cell layers. Nitric ox-
ide (NO) is the best characterized and perhaps most
important mediator which is elaborated in the endo-
thelium as well as in other tissue layers of the vessel
wall [2]. NO has emerged as an important intercellu-
lar and intracellular messenger controlling numerous
biochemical, physiological, and cellular processes in
the vessel wall. Although the in£uence of the endo-
thelium and NO on arterial tone, contractile reactiv-
ity, and other aspects of vascular smooth muscle
physiology has been reasonably well studied, their
in£uence on the energy metabolism of the vessel
has not been examined. The purpose of this investi-
gation was to examine oxidative metabolic variables
of segments of intact porcine carotid arteries with
and without intact endothelia, and to determine
what e¡ect NO produced endogenously in the vessel
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wall may exert on smooth muscle metabolism. It was
shown that endogenously produced NO depresses
oxidative metabolism.
2. Materials and methods
Porcine carotid arteries were obtained shortly after
killing (approx. 15 min) from a local slaughterhouse.
Helical strips were prepared, mounted in organ
baths, attached to force transducers for force record-
ings, and stretched to simulate 100 mmHg mean ar-
terial pressure [3^5]. The arteries were handled in
such manner as to preserve the endothelium intact.
To remove the endothelium, the endothelial surface
was rubbed gently with a forceps. Following this, the
arteries were mounted and brie£y treated for 30 s
with normal incubation medium containing 2 mg/
ml of deoxycholate [6,7] after which time the deoxy-
cholate was removed by four rinses with fresh incu-
bation medium. The incubation medium consisted of
(in mM) 118 NaCl, 20 NaHCO3, 4.7 KCl, 1.2 KH2
PO4, 1.2 MgSO4, 1.6 CaCl2, and 5.6 glucose at 37‡C.
It was aerated with a gas mixture of 95% O2/5%
CO2. The arterial preparations were pre-incubated
in this medium for 1 h, after which time the medium
was changed, the passive tension on the arterial
strips was readjusted, and the incubation continued
for an additional 3 h. In some experiments, 0.3 mM
Ng-nitro-L-arginine methyl ester (L-NAME) was in-
cluded in the incubation medium to inhibit nitric
oxide synthase, and thus, the production of endoge-
nous nitric oxide [2].
2.1. Substrate oxidation
Glucose oxidation and fatty acid (octanoate) oxi-
dation was determined based on the production of
3H2O from metabolism of [6-3H]glucose (40 WCi/
100 ml) and [8-3H]octanoate (100 WCi/100 ml), re-
spectively [4,5]. The 3H2O present in aliquots of
incubation medium was separated from the remain-
ing labeled substrate by using anion exchange col-
umn chromatography as previously described [4]. O2
consumption was measured by using a polaro-
graphic electrode embedded in a sealed organ bath
[3]. After incubation, the arteries were blotted and
weighed.
2.2. Nitric oxide metabolites
A stable product of NO metabolism is nitrite
(NO32 ) which re£ects NO production [2,8]. This
was measured in aliquots (0.5 ml) of incubation me-
dium using the Greiss reaction [8]. Trace nitrite mea-
sured in the incubation medium at time 0 was sub-
tracted from the level measured at 180 min to obtain
total nitrite produced over 3 h of incubation.
2.3. High-energy phosphates
The content of ATP and phosphocreatine was
measured in perchloric acid extracts of arteries. After
incubation, the arteries were rapid frozen in liquid
N2 and pulverized to a ¢ne powder. Perchloric acid
extracts were prepared as previously described and
ATP and phosphocreatine were measured using an
enzymatic assay [9].
All chemicals and enzymes were purchased from
Sigma. [6-3H]glucose was purchased from NEN and
[8-3H]octanoate was purchased from American Ra-
diolabeled Chemicals (St. Louis, MO).
2.4. Statistics
A Student’s t-test for paired comparisons was used
to assess a change within the same group. When
comparing means of three or more groups, one-way
analysis of variance (ANOVA) followed by the Bon-
ferroni multiple comparisons test was used. Re-
peated-measures ANOVA followed by the Bonferro-
ni multiple comparisons test was used to assess
statistical signi¢cance of di¡erences in concentra-
tion^response relationships and di¡erences in meta-
bolic rates and other variables between di¡erent ex-
perimental conditions. Unless noted otherwise, n
refers to the number of experiments, each with at
least two di¡erent carotid arteries from di¡erent an-
imals. A P value of less than 0.05 was signi¢cant.
3. Results
3.1. Vasorelaxation and contractile responsiveness
The functional state of the endothelium and NO-
dependent vasodilating responsiveness of porcine
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carotid artery strips was assessed by contracting the
arteries with a maximal dose of norepinephrine (300
WM, determined by the concentration^response rela-
tionship) and then challenging the arterial strips with
acetylcholine (ACh), an endothelial and NO-depen-
dent vasodilating agonist [1,2,10]. Table 1 gives the
maximal isometric force generated in response to NE
and the subsequent change in force upon treatment
with acetylcholine. In endothelial-intact arteries
which were generating maximal isometric force, in-
troduction of 1 WM acetylcholine to the organ bath
produced the expected vasorelaxation and reduction
in isometric force (28 þ 4%). Addition of 10 WM ACh
did not result in further reduction of force (Table 1).
In endothelial-intact arteries which were treated with
L-NAME, an inhibitor of nitric oxide synthase and
thus NO production, challenge with ACh did not
result in relaxation. Rather, isometric force increased
by 23 þ 4% at 1 WM ACh. At 10 WM ACh there was
an even greater increase in isometric force (56 þ 9%).
These results verify the functional integrity of the
endothelium of the arterial strip preparation, and
the NO-dependency of the vasorelaxation induced
by ACh. In endothelial-denuded arteries, 1 WM
ACh did not produce vasorelaxation, but vasocon-
striction as evidenced by the increase in force
(27 þ 4%), thereby verifying the functional removal
of the endothelium of the preparation. Increasing
the ACh concentration to 10 WM also did not pro-
duce vasorelaxation in denuded arteries, and there
was no additional increase in isometric force above
the level of that at 1 WM ACh.
When L-NAME was included in the incubation
medium with endothelial-denuded arteries, there
was again no vasorelaxation in response to 1 WM
ACh, but vasoconstriction (isometric force increased
by 22 þ 4%). In contrast to the case in the absence of
L-NAME, increasing the concentration of ACh to 10
WM produced an additional increase in force by
55 þ 12%. This suggested that despite the functional
removal of the endothelium and abolition of endo-
thelial-dependent vasorelaxation responsiveness to
ACh, NO production of the arteries was not elimi-
nated and the NO produced was a¡ecting the con-
tractile reactivity of the arterial strips.
The hypothesis that endothelial-denuded arteries
retained the ability to produce NO was tested by
measuring the quantity of a stable product of NO
metabolism, NO32 (nitrite), present in the incubation
medium. At the end of 3 h of incubation, the nitrite
produced by endothelial-intact resting arteries was
125 þ 33 nmol/g (n = 4). Nitrite was also measurable
in the incubation medium bathing endothelial-de-
nuded arteries (88 þ 33 nmol/g, n = 4) con¢rming
the assertion that despite de-endothelialization, the
preparation continued to produce NO. There was
no signi¢cant di¡erence in nitrite production in en-
dothelial-intact, when compared to endothelial-de-
nuded arteries. Treatment of arteries with L-NAME
signi¢cantly inhibited nitrite formation (1 þ 20 nmol/
g; n = 10, P6 0.01).
The e¡ect of removal of the endothelium and the
involvement of NO in contractile responsiveness of
porcine carotid artery was further assessed by exam-
ining the concentration^response relationship in re-
sponse to contractile stimulation by K depolariza-
tion (Fig. 1). Treatment of endothelial-intact arteries
with L-NAME produced a leftward shift in the con-
centration^response curve and a signi¢cant decrease
in the EC50 (Table 2). Denudation of the endothe-
Table 1
E¡ect of removal of endothelium on NO-dependent vasorelaxation
Condition NE maximum force Change in force
ACh, 1 WM ACh, 10 WM
Endothelium-intact 38 þ 4 311 þ 3 310 þ 3
Endothelium-denuded 30 þ 3 +8 þ 1 +9 þ 2
Endothelium-intact+L-NAME 32 þ 3 +7 þ 1 +16 þ 3*
Endothelium-denuded+L-NAME 36 þ 4 +8 þ 2 +18 þ 3*
Arteries were contracted with a maximal concentration of norepinephrine (NE) (300 WM). While maintaining isometric force, the ar-
teries were subsequently challenged with acetylcholine (ACh). The change in force from the level during NE contraction was then
noted. Values represent mean þ S.E., n = 16 arteries from di¡erent animals in each condition. *P6 0.05 when compared with ACh,
1 WM.
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lium produced a rightward shift in the concentration
response relationship and a signi¢cant increase in the
EC50. Subsequent treatment of endothelial-denuded
arteries with L-NAME normalized the concentra-
tion^response relationship, shifting the curve left-
ward (Fig. 1 and Table 2).
3.2. Oxidative metabolism
After having demonstrated that contractile func-
tion of the intact artery is signi¢cantly in£uenced
by the endothelium and the NO system, it was of
interest to determine their respective roles in the en-
ergy metabolism of the arteries. Accordingly, meta-
bolic variables of the endothelial-intact and endothe-
lial-denuded arteries were measured. Fig. 2 shows the
time course of the oxidation of glucose of both prep-
arations. In endothelial-intact arteries the oxidation
of glucose proceeded at a constant rate with time. In
contrast, the rate of glucose oxidation by endothe-
lial-denuded arteries initially remained constant, but
after approx. 120 min of incubation in PSS, the rate
of glucose oxidation declined. By the end of 3 h,
2.22 þ 0.12 Wmol/g glucose had been oxidized by en-
dothelial-intact arteries, whereas, 1.26 þ 0.13 Wmol/g
glucose had been oxidized by endothelial-denuded
arteries (n = 6, P6 0.0005). The oxidation of fatty
acid was also assessed in endothelial-intact and de-
nuded arteries (Fig. 3). The oxidation of the fatty
acid octanoate was signi¢cantly depressed in endo-
thelial-denuded arteries, (1.10 þ 0.04 Wmol/g per 3 h
vs. 0.91 þ 0.04 Wmol/g per 3 h; P6 0.013, n = 4) in-
dicating that removal of the endothelium depressed
Table 2
Contractile responsiveness of carotid arteries to K depolarization
Condition EC50 (mM) Maximal force (g)
Endothelial-intact (control) 25.9 þ 1.5 68.1 þ 4.2
Endothelial-denuded 32.9 þ 1.5* 50.0 þ 4.2*
Endothelial-intact+L-NAME 20.6 þ 1.5* 74.8 þ 4.2
Endothelial-denuded+L-NAME 26.6 þ 1.5 61.0 þ 4.2
Values represent means þ S.E., n = 16 di¡erent carotid arteries from di¡erent animals in each experimental condition. *P6 0.05 when
compared with control.
Fig. 2. Glucose oxidation and the e¡ect of NO in endothelial-
intact and endothelial-denuded arteries. Values represent mean-
s þ S.E. (a) Endothelial-intact arteries; (b) endothelial-denuded
arteries; (E) endothelial-intact arteries+L-NAME; (F) endothe-
lial-denuded arteries+L-NAME. n = 6 experiments in each
group, each with two di¡erent carotid arteries from di¡erent
animals. *P6 0.0001.
Fig. 1. Concentration^response relationships to K depolariza-
tion of endothelial-intact and endothelial-denuded arteries. Val-
ues represent means þ S.E. (a) Endothelial-intact arteries; (b)
endothelial-denuded arteries; (E) endothelial-intact arteries+L-
NAME; (F) endothelial-denuded arteries+L-NAME. All con-
centration^response curves signi¢cantly di¡erent from one an-
other (P6 0.05). n = 16 di¡erent arteries from di¡erent animals
in each experimental group.
BBABIO 45088 14-12-01
J.T. Barron et al. / Biochimica et Biophysica Acta 1506 (2001) 204^211 207
oxidative metabolism of the tissue. The involvement
of NO in depression of oxidation of substrates was
assessed by measuring the oxidation of glucose in
endothelium-denuded arteries in the presence of L-
NAME (Fig. 2). Glucose oxidation by denuded ar-
teries under these conditions was no di¡erent from
control, i.e., L-NAME negated the e¡ect of removal
of the endothelium on oxidative metabolism (Fig. 2).
L-NAME had no e¡ect on glucose oxidation in en-
dothelial-intact arteries.
Further evidence that the endothelium and NO
play a role in the oxidative metabolism of arteries
was obtained from measurement of O2 consumption
in endothelial-intact and endothelial-denuded ar-
teries. Oxygen consumption in endothelium-denuded
arteries (0.41 þ 0.02 Wmol/g per min, n = 13) was sig-
ni¢cantly less than that of endothelial-intact arteries
(0.55 þ 0.04 Wmol/g per min, n = 11, P6 0.01). There
was no di¡erence between the blotted wet weights
of endothelial-intact arteries and endothelial-de-
nuded arteries used for O2 consumption measure-
ments (0.441 þ 0.011 g, n = 25) vs. (0.445 þ 0.013 g,
n = 25; P = not signi¢cant (NS)). L-NAME com-
pletely normalized O2 consumption in endothelial-
denuded arteries, suggesting that NO was involved
in depression of O2 consumption of vascular smooth
muscle (Fig. 4).
The fact that L-NAME reversed the depression of
oxidative metabolism in endothelial-denuded arteries
indicates that such depression could not be due to
loss of the portion of total tissue respiration contrib-
uted by the endothelium. Also, the depression in oxi-
dative metabolism was not due to a change in the
energy requirements of the muscles since there was
no di¡erence in resting tone of the arteries in any
experimental condition (data not shown). Further-
more, there was no di¡erence in high energy phos-
phate content (ATP+phosphocreatine) in endothe-
lial-intact and endothelial-denuded arteries (2.38 þ
0.05 Wmol/g vs. 2.34 þ 0.13 Wmol/g; n = 8, P = NS).
When comparing O2 consumption of endothelial-
intact arteries in the presence or absence of L-NAME
(Fig. 4), arteries treated with L-NAME displayed a
9.3 þ 2.9% increase in O2 consumption from the
basal rate before treatment for 3 h with L-NAME
(n = 11, P6 0.005; t-test of paired comparisons). By
contrast, O2 consumption of control, endothelial-in-
tact arteries not treated with L-NAME, did not
Fig. 4. O2 consumption and the e¡ect of NO in endothelial-in-
tact and endothelial-denuded arteries. Basal O2 consumption
was measured after 1 h incubation in normal medium. Subse-
quently, either the endothelial layer was removed and/or the in-
cubation medium was changed to the one indicated. O2 con-
sumption was again measured 3 h later and the change from
the pre-treatment rate was noted. Values represent means þ S.E.
and are expressed in terms of percent change from the pre-
treatment rate in the same arteries. Open bars, endothelial-in-
tact arteries; hatched bars, endothelial-denuded arteries. Num-
bers in parentheses (n) indicate number of experiments each
with two di¡erent arteries from di¡erent animals. *P6 0.05,
when compared to endothelial-intact arteries, in the absence of
L-NAME (control).
Fig. 3. Free fatty acid oxidation in endothelial-intact and endo-
thelial-denuded arteries. Values represent means þ S.E. (a) En-
dothelial-intact arteries; (b) endothelial-denuded arteries. n = 4
experiments in each group, each with two di¡erent carotid ar-
teries from di¡erent animals. *P6 0.013.
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change from the basal rate after additional incuba-
tion in normal medium (0.5 þ 1.8%; n = 11, P = NS).
The increase in O2 consumption in the presence of L-
NAME was signi¢cantly increased when compared
to control. These results suggest that endogenous
NO produced from cells in the vessel wall did have
a small but detectable inhibitory e¡ect on tissue res-
piration even in endothelial-intact arteries.
4. Discussion
4.1. Endothelium-dependent e¡ects
The role of the endothelium in the energy metab-
olism of arteries has received little investigation. One
early report indicated that O2 consumption and glu-
cose metabolism in isolated segments of rat aorta
were signi¢cantly di¡erent if the segments were pre-
pared in such a way as to preserve the endothelium
intact, as compared to when the endothelium was
disrupted [11]. Rat aortae with intact endothelia ex-
hibited a greater rate of O2 consumption and glucose
oxidation than aortae with disrupted endothelia. The
results with porcine carotid arteries in the present
investigation are in agreement with this previous re-
port. We also demonstrated that fatty acid oxidation
was also signi¢cantly decreased when the endothelial
layer was removed, indicating that the e¡ect of en-
dothelial denudation was not speci¢c to glucose me-
tabolism. Rather, the results showing depression of
glucose metabolism, fatty acid oxidation, and O2
consumption suggest that the endothelial denudation
had a general a¡ect on oxidative metabolism.
Removal of the endothelial layer, in addition to
depressing oxidative metabolism, also depressed con-
tractile responsiveness. There was a rightward shift in
the concentration^response relationship to K-depo-
larization, a signi¢cant increase in EC50 to KCl, and
a signi¢cant decrease in maximal force generated.
The endothelium is known to secrete several vaso-
active mediators that may either enhance or depress
resting tone and/or contractility of the underlying
media muscularis [1,12]. The summed e¡ect of the
various vasoactive factors on contractile reactivity
would depend on the physiological milieu and the
activating stimuli. Conversely, withdrawal of these
mediators would also variably a¡ect contractile re-
sponsiveness. In porcine carotid artery, the net e¡ect
of removal of endothelium was apparently depres-
sion of contractile responsiveness of the smooth
muscle. By contrast, resting tone was apparently un-
a¡ected since there was no di¡erence in the resting
tension between the endothelial-intact and endothe-
lial-denuded preparations (data not shown).
4.2. Nitric oxide-dependent e¡ects
The experimental evidence indicated that NO was
responsible for the depression in O2 consumption
and oxidative metabolism in endothelial-denuded ar-
teries. Depression of O2 consumption was eliminated
by L-NAME. Similarly, L-NAME normalized glucose
oxidation and O2 consumption in endothelial-de-
nuded arteries. The depression of metabolism in vas-
cular smooth muscle by NO is consistent with other
reports of its metabolic action in other tissues [13^
16]. NO has been reported to suppress O2 consump-
tion and mitochondrial respiration in cardiac muscle
and other tissues by competing with molecular O2 at
the mitochondrial electron transport chain. Speci¢-
cally, cytochrome c oxidase activity may be compet-
itively inhibited by NO [13,18,19]. NO has also been
demonstrated to govern the proton gradient, and
hence, the electrical potential across the inner mito-
chondrial membrane. Ghafourihar and Richter [17]
demonstrated that exogenously added NO caused a
dose-dependent acidi¢cation of the inner mitochon-
drial matrix resulting in a drop in the mitochondrial
transmembrane potential. Activation of mitochon-
drial ATP-dependent K channels is another re-
ported action of NO which could a¡ect mitochon-
drial function [20]. These actions of NO could have
important consequences on oxidative metabolism of
the tissue. Dissipation of the mitochondrial trans-
membrane potential and direct inhibition of O2 con-
sumption could adversely a¡ect the oxidation of sub-
strates. In contrast to these studies, other studies
with skeletal muscle report that NO stimulates oxi-
dative metabolism by a cGMP-mediated mechanism
involving activation of cGMP-mediated protein ki-
nase (PKG) [21^23]. The authors of the studies
speculated that activation of PKG and attendant
stimulation of oxidation of metabolic fuels may
supersede any inhibiting e¡ect of NO on respiration.
Thus, NO may have multiple counterbalancing ef-
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fects on cellular energy producing pathways. In our
study with vascular smooth muscle, the prevailing
e¡ect of NO appears to be suppression of O2 con-
sumption and oxidation of metabolic fuels.
The evidence indicated that the depression of con-
tractile reactivity to K depolarization was also in
large part due to NO. Treatment of the de-endothe-
lialized arterial strips with L-NAME improved con-
tractile reactivity. NO is known to depress contractile
responsiveness of vascular smooth muscle [24,25],
and was probably responsible for the rightward shift
in the concentration^response relationship (relative
to the concentration^response relationship in the
presence of L-NAME) in endothelial-denuded prepa-
rations, and also in endothelial-intact preparations.
However, the concentration^response relationship in
endothelial-denuded arteries did not completely nor-
malize upon treatment with L-NAME and it was still
shifted rightward relative to endothelial-intact ar-
teries which were also treated with L-NAME. There-
fore, the depression of contractile responsiveness in
endothelial-denuded arteries was greater then what
could be completely attributed to NO alone. Rather,
removal of the endothelium may have concomitantly
resulted in withdrawal of other endothelial-derived
factors which have vasoconstrictive properties (e.g.,
endothelin) and which might have counterbalanced
the vasodepressive action of NO.
4.3. Extra-endothelial source of NO
Quiescent, resting porcine vascular endothelial
cells in culture produce little or no ambient NO
which can be detected in the incubation medium un-
less the cells are activated by physiological stimuli
such as stretch or vasoactive agents which increase
the in£ux of Ca2 [26]. Ca2 in£ux is apparently
crucial for NO generation by nitric oxide synthase
in endothelial cells both under basal conditions and
upon stimulation by pharmacological agonists, such
as acetylcholine [27^30]. Because NO production (as
re£ected by total nitrite production) was not changed
when the endothelium was removed, it is assumed
that the majority of ambient NO production in the
intact resting artery originated not from the endothe-
lium, but from other cells in the tunica media mus-
cularis or tunica adventitia. Several cells of the vessel
wall including macrophages, ¢broblasts and vascular
smooth muscle cells have the ability to elaborate NO
and other vasoactive substances such as superoxide
in cell culture [2,31]. In fact, ¢broblasts from adven-
titia were demonstrated to be a major source of NO
and superoxide production in intact rat or mouse
aortae [31,32]. Nevertheless, the ambient NO produc-
tion from cells in the vessel wall other than endothe-
lial cells might also be expected to depress oxidative
metabolism in endothelial-intact arteries, as occurred
in endothelial-denuded arteries. Indeed, there was a
small but signi¢cant (approx. 9%) increase in O2
consumption in endothelial-intact arteries when
treated with L-NAME and L-NAME did produce a
leftward shift in the concentration response relation-
ship to KCl. However, an e¡ect on glucose oxidation
was not detected most likely because any increase
would be small and would be di⁄cult to detect due
to the limitation of the analytical methods for deter-
mination of glucose oxidation. The relatively small
e¡ect of endogenous NO production on endothelial-
intact arteries, in comparison to endothelial-denuded
arteries, may be due to multiple factors. It may be
the case that higher concentrations of NO are needed
to a¡ect the energy metabolism of vascular smooth
muscle. In this context it is worth noting that recent
evidence suggests that the concentration of bioactive
NO is decreased in muscle cells because of the pres-
ence of myoglobin. Myoglobin acts essentially as a
scavenger of bioactive NO [33,34]. In an analogous
manner, the endothelium may have exerted an e¡ect
in endothelium-intact arteries to counteract the met-
abolic actions of NO produced from the subjacent
vessel wall layers by inactivating NO. Incomplete
removal of the endothelium and di¡erential sensitiv-
ity to the inhibitory action of NO of di¡erent cell
types in the vessel wall may also account for the
experimental observations that L-NAME reversed
the depression of O2 consumption in ‘endothelial-de-
nuded’ arteries. Alternatively, the endothelium may
have counteracted the inhibitory metabolic e¡ects of
NO by elaborating some endothelial-derived ‘metab-
olism regulating factor’.
In summary, our results show that the removal or
disruption of vascular endothelial layer results in de-
pression in oxidative metabolism and contractility of
carotid artery. It was also shown that such depres-
sion was attributed to NO which likely originated
from cells within the tunica media muscularis and/
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or adventitia. The endothelium modulates oxidative
metabolism of the vessel wall possibly by modulating
the e¡ects of NO and perhaps other substances pro-
duced by other cells, or by other factors. The regu-
lation of the production of NO in extra-endothelial
cells in the intact artery is not de¢ned at present.
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